Cargando…

Developing a Bayesian adaptive design for a phase I clinical trial: a case study for a novel HIV treatment

The design of phase I studies is often challenging, because of limited evidence to inform study protocols. Adaptive designs are now well established in cancer but much less so in other clinical areas. A phase I study to assess the safety, pharmacokinetic profile and antiretroviral efficacy of C34‐PE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mason, Alexina J., Gonzalez‐Maffe, Juan, Quinn, Killian, Doyle, Nicki, Legg, Ken, Norsworthy, Peter, Trevelion, Roy, Winston, Alan, Ashby, Deborah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2016
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412923/ https://www.ncbi.nlm.nih.gov/pubmed/27891651 http://dx.doi.org/10.1002/sim.7169

Ejemplares similares

A first-in-human study of the novel HIV-fusion inhibitor C34-PEG(4)-Chol
por: Quinn, Killian, et al.
Publicado: (2017)

A Bayesian framework for health economic evaluation in studies with missing data
por: Mason, Alexina J., et al.
Publicado: (2018)

Protocol for a randomised controlled trial of VAsopressin versus Noradrenaline as Initial therapy in Septic sHock (VANISH)
por: Gordon, Anthony C, et al.
Publicado: (2014)

Handling Missing Data in Within-Trial Cost-Effectiveness Analysis: A Review with Future Recommendations
por: Gabrio, Andrea, et al.
Publicado: (2017)

Erratum to: Handling Missing Data in Within-Trial Cost-Effectiveness Analysis: A Review with Future Recommendations
por: Gabrio, Andrea, et al.
Publicado: (2017)

Biomarker associations with insomnia and secondary sleep outcomes in persons with and without HIV in the POPPY-Sleep substudy: a cohort study
por: Bakewell, Nicholas, et al.
Publicado: (2022)

An efficacy and mechanism evaluation study of Levosimendan for the Prevention of Acute oRgan Dysfunction in Sepsis (LeoPARDS): protocol for a randomized controlled trial
por: Orme, Robert M L’E, et al.
Publicado: (2014)

BASIC: A Bayesian adaptive synthetic-control design for phase II clinical trials
por: Jiang, Liyun, et al.
Publicado: (2023)

Comparison of a frequentist and Bayesian response-adaptive randomisation approach in multi-stage phase II selection trials with multiple experimental arms
por: Yap, Christina, et al.
Publicado: (2015)

Practical recommendations for implementing a Bayesian adaptive phase I design during a pandemic
por: Ewings, Sean, et al.
Publicado: (2022)

A Bayesian Model of Sensory Adaptation
por: Sato, Yoshiyuki, et al.
Publicado: (2011)

Using Bayesian adaptive designs to improve phase III trials: a respiratory care example
por: Ryan, Elizabeth G., et al.
Publicado: (2019)

A Bayesian Adaptive Design for Combination of Three Drugs in Cancer Phase I Clinical Trials
por: Tighiouart, Mourad, et al.
Publicado: (2016)

A Bayesian predictive approach for dealing with pseudoreplication
por: Lazic, Stanley E., et al.
Publicado: (2020)

The use of funnel plots with regression as a tool to visually compare HIV treatment outcomes between centres adjusting for patient characteristics and size: a UK Collaborative HIV Cohort study
por: Gompels, M, et al.
Publicado: (2018)

A flexible hierarchical framework for improving inference in area-referenced environmental health studies [Image: see text]
por: Pirani, Monica, et al.
Publicado: (2020)

Bayesian adaptive algorithms for locating HIV mobile testing services
por: Gonsalves, Gregg S., et al.
Publicado: (2018)

A Bayesian Adaptive Design in Cancer Phase I Trials Using Dose Combinations with Ordinal Toxicity Grades
por: Diniz, Márcio A, et al.
Publicado: (2020)

Development of a practical approach to expert elicitation for randomised controlled trials with missing health outcomes: Application to the IMPROVE trial
por: Mason, Alexina J, et al.
Publicado: (2017)

The Bayesian Design of Adaptive Clinical Trials
por: Giovagnoli, Alessandra
Publicado: (2021)

Association between inflammatory biomarker profiles and cardiovascular risk in individuals with and without HIV
por: Sukumaran, Luxsena, et al.
Publicado: (2023)

A Bayesian adaptive design for biomarker trials with linked treatments
por: Wason, James M S, et al.
Publicado: (2015)

Estimation of Olfactory Sensitivity Using a Bayesian Adaptive Method
por: Höchenberger, Richard, et al.
Publicado: (2019)

A Bayesian adaptive design for clinical trials in rare diseases
por: Williamson, S. Faye, et al.
Publicado: (2017)

A novel Bayesian adaptive method for mapping the visual field
por: Xu, Pengjing, et al.
Publicado: (2019)

Adaptive designs for phase II cross-over dose-finding trials using Bayesian model averaging
por: Simpson, Sarah, et al.
Publicado: (2015)

Frequentist and Bayesian Quantum Phase Estimation
por: Li, Yan, et al.
Publicado: (2018)

A Novel Bayesian Seamless Phase I/II Design
por: Pan, Haitao, et al.
Publicado: (2013)

Interpreting a Bayesian phase II futility clinical trial
por: Beall, Jonathan, et al.
Publicado: (2022)

Adaptive Naive Bayesian Anti-Spam Engine
por: Gajewski, W P
Publicado: (2006)

Bayesian adaptive clinical trials of combination treatments
por: Thorlund, Kristian, et al.
Publicado: (2017)

Adaptive Tree Proposals for Bayesian Phylogenetic Inference
por: Meyer, X
Publicado: (2021)

A Bayesian Account of Vocal Adaptation to Pitch-Shifted Auditory Feedback
por: Hahnloser, Richard H. R., et al.
Publicado: (2017)

Validation of a Bayesian Adaptive Estimation Technique in the Stop-Signal Task
por: Livesey, Evan J., et al.
Publicado: (2016)

Adaptive Bayesian credible bands in regression with a Gaussian process prior
por: Sniekers, Suzanne, et al.
Publicado: (2019)

A data-adaptive Bayesian regression approach for polygenic risk prediction
por: Song, Shuang, et al.
Publicado: (2022)

SCI: A Bayesian adaptive phase I/II dose‐finding design accounting for semi‐competing risks outcomes for immunotherapy trials
por: Zhang, Yifei, et al.
Publicado: (2022)

Are large randomised controlled trials in severe sepsis and septic shock statistically disadvantaged by repeated inadvertent underestimates of required sample size?
por: Wong, Joshua L C, et al.
Publicado: (2018)

A framework for extending trial design to facilitate missing data sensitivity analyses
por: Mason, Alexina J., et al.
Publicado: (2020)

Suppurative Pericarditis: Report of a Case, and Some Important Objective Signs for Diagnosing Pericardial Effusion
por: Norsworthy, C. L.
Publicado: (1895)

Cannot write session to /tmp/vufind_sessions/sess_lntj8f9augauftha2v2mnsu8ad